Aardvark Therapeutics Inc...

NASDAQ: AARD · Real-Time Price · USD
10.76
-0.50 (-4.44%)
At close: Aug 15, 2025, 3:59 PM
10.78
0.19%
After-hours: Aug 15, 2025, 04:10 PM EDT

Aardvark Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Net Income
-14.37M -9.31M -8.78M -4.18M -5.45M -2.18M -2.04M -2.11M
Depreciation & Amortization
-620K 5K -121K 87K 48K 2K 25K 26K
Stock-Based Compensation
634K 233K 173K 145K 54K 67K 69K 72K
Other Working Capital
n/a -3M -378K 488K 539K 126K -238K -260K
Other Non-Cash Items
4.51M 41K 185K 91K -41K 238K 97K 742K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
n/a -2.36M 815K -96K 1.17M -319K 694K -316K
Operating Cash Flow
-9.84M -11.39M -7.73M -3.96M -4.21M -2.19M -1.16M -1.58M
Capital Expenditures
-91K n/a -6K -5K -93K -5K n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a -124.65M n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
9.5M 12.03M n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a -11.89M n/a n/a n/a n/a n/a
Investing Cash Flow
9.41M -112.62M -11.89M -5K -93K -5K n/a n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-71K n/a -1.18M 64K 82.94M n/a n/a n/a
Financial Cash Flow
-71K 88.88M -1.01M 64K 82.94M n/a n/a n/a
Net Cash Flow
-506K -35.14M -20.64M -3.9M 78.63M -2.19M -1.16M -1.58M
Free Cash Flow
-9.94M -11.39M -7.73M -3.96M -4.31M -2.19M -1.16M -1.58M